134940.fig.001a
(a)
134940.fig.001b
(b)
134940.fig.001c
(c)
134940.fig.001d
(d)
134940.fig.001e
(e)
134940.fig.001f
(f)
Figure 1: (a) DMSA kidney scintigraphy that indicates normal activity retention in the 3rd day in control group (pyelonephritis score: 0). (b)DMSA kidney scintigraphy in the 3rd day in ceftriaxone group (pyelonephritis score: 1). (c) DMSA kidney scintigraphy in the 3rd day in ceftriaxone-ketoprophen group (pyelonephritis score: 3). (d) DMSA kidney scintigraphy in the 10th week in no-treatment group (scar score: 2). (e) DMSA kidney scintigraphy in the 10th week in ceftriaxone group (scar score: 1). (f) DMSA kidney scintigraphy in the 10th week in Ceftriaxone − Ketoprophen Group (scar score: 0).